Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
International Study to Predict Optimised Treatment in Depression (iSPOT-D)
2008-004122-17Phase 4Terminated
- Sponsor
- Biopharmaceutical Research Company
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of escitalopram, sertraline and venlafaxine in major depressive disorder (MDD) (4 arms), sponsored by Biopharmaceutical Research Company. Primary endpoint: Reasons for discontinuation of treatment. Started Aug 2008; status: terminated.
02
Drugs
escitalopramsertralinevenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2008-004122-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004122-17.